CEREVASC, INC.
Profile
Company Names
CEREVASC, INC.
Addresses
2120 COMMONWEALTH AVE., SUITE 1, AUBURNDALE, MA 02466
Phone Numbers
617-584-1622
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2020
State Incorporated:
DELAWARE
Total Amount Raised:
$11,052,975.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-05-22
$11,052,975.00
$32,452,974.00
$21,399,999.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
FREDERICK
CALLORI
DIRECTOR
CHRIS
GARABEDIAN
DIRECTOR
QUELLIS BIOSCIENCES, INC.
| VYOME THERAPEUTICS INC.
| CEREVASC, INC.
| NEPHRODI THERAPEUTICS, INC.
| FORGE BIOLOGICS HOLDINGS, LLC
| SHIFA BIOMEDICAL CORP
| JUNO DIAGNOSTICS, INC.
| TELLUS THERAPEUTICS, INC.
| STREAM BIOMEDICAL, INC.
| POLYCORE THERAPEUTICS, INC.
| VIVOSENSE, INC.
| ASCLEPIX THERAPEUTICS, INC.
| MAREA THERAPEUTICS, INC.
| ZUCARA THERAPEUTICS INC.
PATRICK
SULLIVAN
DIRECTOR
RIGHTSFLOW, INC.
| HOUSTON INTERNATIONAL INSURANCE GROUP
| BAIN CAPITAL FUND XI, L.P.
| BC XI PRIVATE INVESTORS, L.P.
| FERTILITY LEADERS OF TEXAS, LLC
| HIGHPOINT LUMA WPB, LLC
| HP MULTIFAMILY FUND I, LLC
| HP MULTIFAMILY FUND II, LLC
| ARGONAUT PRIVATE EQUITY FUND IV, LP
| ARGONAUT PRIVATE EQUITY FUND IV-A, LP
| DEFENDRY, LLC
| CEREVASC, INC.
| SOCIALED, INC.
| LINQ APP INC
| ARGONAUT PRIVATE EQUITY FUND V, LP
| ARGONAUT PRIVATE EQUITY FUND V-A, LP
| 26NORTH BDC, INC.
| APE VI YQB CO-INVEST, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
